Karyopharm Therapeutics Inc. buy HC Wainwright
Start price
03.08.23
/
50%
€1.62
Target price
03.08.24
€9.14
Performance (%)
-34.99%
Price
03.05.24
€1.05
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Karyopharm Therapeutics Inc. is performing very badly with a performance of -34.99%. This prediction currently runs until 03.08.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Karyopharm Therapeutics Inc. | 5.303% | 5.303% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by HC_Wainwright for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by HC_Wainwright for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.49
26.07.23
26.07.23
€9.03
26.07.24
26.07.24
-29.35%
03.05.24
03.05.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.48
18.07.23
18.07.23
€8.90
18.07.24
18.07.24
-28.97%
03.05.24
03.05.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
20.04.23
20.04.23
€14.57
20.04.24
20.04.24
-69.78%
21.04.24
21.04.24